Volume 17, Number 10—October 2011
Research
Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infection in England and Scotland, 2009–2010
Laurence Calatayud
, Angie Lackenby, Arlene Reynolds, Jim McMenamin, Nick F. Phin, Maria Zambon, and Richard G. Pebody
, Angie Lackenby, Arlene Reynolds, Jim McMenamin, Nick F. Phin, Maria Zambon, and Richard G. Pebody
Table 2
Type of immunosuppression, presence of hematopoietic cell transplant, and outcomes for patients with oseltamivir-resistant pandemic (H1N1) 2009, England and Scotland, April 2009–April 30, 2010*
| Type of immunosuppression | No. with oseltamivir-resistant strains | No. with hematopoietic cell transplant | No. admitted to ICU | No. deaths |
|---|---|---|---|---|
| Leukemia | ||||
| Acute lymphocytic | 2 | 1 | ||
| Acute myeloid | 3 | 2 | 1 | 1 |
| Chronic lymphocytic | 5 | 2 | 2 | 2 |
| No precision | 1 | |||
| Lymphoma | ||||
| Non-Hodgkin | 2 | 1 | 1 | 1 |
| Marginal zone | 1 | |||
| Mantle cell | 2 | 1 | ||
| Multiple myeloma | 1 | 1 | 1 | |
| Aplastic anemia | 1 | 1 | ||
| Hematologic cancer with no precision | 1 | 1 | ||
| TRAPS | 1 | |||
| HIV | 1 | 1 | ||
| Total | 21 | 8 | 5 | 7
*ICU, intensive care unit; TRAPS, tumor necrosis factor receptor–associated periodic syndrome. |
*ICU, intensive care unit; TRAPS, tumor necrosis factor receptor–associated periodic syndrome.
Page created: September 28, 2011
Page updated: September 28, 2011
Page reviewed: September 28, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.